Advertisement

Hill-Rom's profits fall 27% in third quarter

By Adam Rubenfire  |  August 07, 2015

Medical equipment manufacturer Hill-Rom reported a drop in third-quarter profits as costs outpaced revenue. Nonetheless, the company saw growth in multiple segments.

Premier buys practice-analytics provider CECity

By Adam Rubenfire  |  August 04, 2015

Premier has acquired a Pittsburgh-based analytics software vendor as it seeks to expand its capacity to track value-based care in the ambulatory arena.

Pharma continues to boost Cardinal earnings

By Adam Rubenfire  |  July 30, 2015

Cardinal Health reported higher-than-expected earnings for the fourth quarter and ended the fiscal year with sound financials thanks to significant growth in its pharmaceutical segment.

AbbVie beats 2Q profit forecasts but sales fall short; new drug OK'd

By Associated Press  |  July 24, 2015

Drugmaker AbbVie reported better-than-expected second-quarter profit, but its sales disappointed Wall Street. The FDA on Friday approved a new drug from AbbVie for the treatment of hepatitis C, creating a competitor to one of the most expensive drugs on the market.

Cholesterol drug Praluent approved by FDA

By Associated Press  |  July 24, 2015

The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades. But the drug's $14,600-a-year price tag is certain to escalate debate about the cost of breakthrough drugs.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.